BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1237 related articles for article (PubMed ID: 11714635)

  • 21. Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to Ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells.
    Plattner R; Gupta S; Khosravi-Far R; Sato KY; Perucho M; Der CJ; Stanbridge EJ
    Oncogene; 1999 Mar; 18(10):1807-17. PubMed ID: 10086335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged activation of the mitogen-activated protein kinase pathway is required for macrophage-like differentiation of a human myeloid leukemic cell line.
    Hu X; Moscinski LC; Valkov NI; Fisher AB; Hill BJ; Zuckerman KS
    Cell Growth Differ; 2000 Apr; 11(4):191-200. PubMed ID: 10775036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opposing roles of Ras/Raf oncogenes and the MEK1/ERK signaling module in regulation of expression and adhesive function of surface transglutaminase.
    Akimov SS; Belkin AM
    J Biol Chem; 2003 Sep; 278(37):35609-19. PubMed ID: 12832399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
    Wen-Sheng W
    Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Murine Ksr interacts with MEK and inhibits Ras-induced transformation.
    Denouel-Galy A; Douville EM; Warne PH; Papin C; Laugier D; Calothy G; Downward J; Eychène A
    Curr Biol; 1998 Jan; 8(1):46-55. PubMed ID: 9427625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway.
    Park JI; Strock CJ; Ball DW; Nelkin BD
    Mol Cell Biol; 2003 Jan; 23(2):543-54. PubMed ID: 12509453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cot protooncoprotein activates the dual specificity kinases MEK-1 and SEK-1 and induces differentiation of PC12 cells.
    Hagemann D; Troppmair J; Rapp UR
    Oncogene; 1999 Feb; 18(7):1391-400. PubMed ID: 10050876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A dominant role for the Raf-MEK pathway in forskolin, 12-O-tetradecanoyl-phorbol acetate, and platelet-derived growth factor-induced CREB (cAMP-responsive element-binding protein) activation, uncoupled from serine 133 phosphorylation in NIH 3T3 cells.
    Seternes OM; Johansen B; Moens U
    Mol Endocrinol; 1999 Jul; 13(7):1071-83. PubMed ID: 10406459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Raf-1 mutant that dissociates MEK/extracellular signal-regulated kinase activation from malignant transformation and differentiation but not proliferation.
    Dhillon AS; Meikle S; Peyssonnaux C; Grindlay J; Kaiser C; Steen H; Shaw PE; Mischak H; Eychène A; Kolch W
    Mol Cell Biol; 2003 Mar; 23(6):1983-93. PubMed ID: 12612072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia.
    Blalock WL; Navolanic PM; Steelman LS; Shelton JG; Moye PW; Lee JT; Franklin RA; Mirza A; McMahon M; White MK; McCubrey JA
    Leukemia; 2003 Jun; 17(6):1058-67. PubMed ID: 12764369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ligation of the T cell receptor complex results in activation of the Ras/Raf-1/MEK/MAPK cascade in human T lymphocytes.
    Franklin RA; Tordai A; Patel H; Gardner AM; Johnson GL; Gelfand EW
    J Clin Invest; 1994 May; 93(5):2134-40. PubMed ID: 8182145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoteichoic acid selectively induces the ERK signaling pathway in the cornea.
    You L; Kruse FE; Bacher S; Schmitz ML
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2272-7. PubMed ID: 12091427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element.
    Newberry EP; Willis D; Latifi T; Boudreaux JM; Towler DA
    Mol Endocrinol; 1997 Jul; 11(8):1129-44. PubMed ID: 9212060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. c-Raf/MEK/ERK pathway controls protein kinase C-mediated p70S6K activation in adult cardiac muscle cells.
    Iijima Y; Laser M; Shiraishi H; Willey CD; Sundaravadivel B; Xu L; McDermott PJ; Kuppuswamy D
    J Biol Chem; 2002 Jun; 277(25):23065-75. PubMed ID: 11940578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration.
    Rajalingam K; Wunder C; Brinkmann V; Churin Y; Hekman M; Sievers C; Rapp UR; Rudel T
    Nat Cell Biol; 2005 Aug; 7(8):837-43. PubMed ID: 16041367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation.
    Khosravi-Far R; White MA; Westwick JK; Solski PA; Chrzanowska-Wodnicka M; Van Aelst L; Wigler MH; Der CJ
    Mol Cell Biol; 1996 Jul; 16(7):3923-33. PubMed ID: 8668210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermal growth factor induces c-fos and c-jun mRNA via Raf-1/MEK1/ERK-dependent and -independent pathways in bovine luteal cells.
    Chen DB; Davis JS
    Mol Cell Endocrinol; 2003 Feb; 200(1-2):141-54. PubMed ID: 12644307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Raf-1 is activated by the p38 mitogen-activated protein kinase inhibitor, SB203580.
    Kalmes A; Deou J; Clowes AW; Daum G
    FEBS Lett; 1999 Feb; 444(1):71-4. PubMed ID: 10037150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinase suppressor of ras is necessary for tumor necrosis factor alpha activation of extracellular signal-regulated kinase/mitogen-activated protein kinase in intestinal epithelial cells.
    Yan F; Polk DB
    Cancer Res; 2001 Feb; 61(3):963-9. PubMed ID: 11221891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The JNK/SAPK activator mixed lineage kinase 3 (MLK3) transforms NIH 3T3 cells in a MEK-dependent fashion.
    Hartkamp J; Troppmair J; Rapp UR
    Cancer Res; 1999 May; 59(9):2195-202. PubMed ID: 10232608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.